HAP Trading’s Anavex Life Sciences AVXL Stock Holding History

HAP Trading’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-27,871	Closed	-$530K	–	2525
2021 Q3	$500K	Buy	+27,871	New	+$555K	0.02%	681

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HAP Trading's AVXL Position: Q4 2021 in Review

HAP Trading sold out of Anavex Life Sciences (AVXL) in Q4 2021, closing a stake of 27,871 shares — an estimated $530K sold.

HAP Trading first reported a position in AVXL in Q3 2021 and held it in 1 quarter. The position peaked at $500K in Q3 2021. 149 funds tracked by Wall St. Rank hold AVXL as of Q4 2021.

HAP Trading reported no remaining Anavex Life Sciences position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 27,871 Anavex Life Sciences shares in Q4 2021, an estimated $530K.
HAP Trading first reported a position in Anavex Life Sciences in Q3 2021 and held it in 1 quarter.
HAP Trading's Anavex Life Sciences position peaked at $500K in Q3 2021.
149 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.